Amplitude, Inc. (AMPL): A Bull Case Theory
We came across a bullish thesis on Amplitude, Inc. (AMPL) on Value Investing Subreddit Page by sketchfag. In this article, we ...
TipRanks on MSN11h
Amplitude Inc’s AI Ambitions: Balancing Innovation with Risk Management
Amplitude Inc Class A (AMPL) has disclosed a new risk, in the Innovation / R&D category. Amplitude Inc Class A faces significant risks if it fails ...
Amplitude Full Year 2024 Earnings: EPS Misses Expectations
Full Year 2024 Results Key Financial Results Revenue: US$299.3m (up 8.3% from FY 2023).
UBS Group Issues Positive Forecast for Amplitude (NASDAQ:AMPL) Stock Price
Amplitude (NASDAQ:AMPL – Get Free Report) had its target price lifted by equities researchers at UBS Group from $10.00 to $13.00 in a research report issued on Thursday,Benzinga reports. The brokerage ...
Amplitude's Expanding Product Suite & Enterprise Surge Position It for Stronger Growth, Says Analyst
Piper Sandler raises Amplitude's price target to $17, citing strong multi-product momentum, enterprise growth, and the ...
Amplitude price target raised to $16 from $14 at BofA
BofA raised the firm’s price target on Amplitude (AMPL) to $16 from $14 and keeps a Buy rating on the shares after the company reported “solid” ...
Amplitude (NASDAQ:AMPL) Hits New 52-Week High Following Analyst Upgrade
Shares of Amplitude, Inc. (NASDAQ:AMPL – Get Free Report) hit a new 52-week high on Thursday after Morgan Stanley raised their price target on the stock from $11.00 to $13.00. Morgan Stanley currently ...
Amplitude jumps as brokerages raise rating on upbeat 2025 earnings forecast
Shares of Amplitude (NASDAQ:AMPL) jumped on Thursday as the digital analytics platform provider forecasted an upbeat 2025 and posted better-than-expected results a day earlier. Following the positive ...
Amplitude integrates in-app surveys into its behavioral analysis platform
Behavior-tracking software firm Amplitude Inc. today said it has completed the integration of the personalized user ...
Amplitude Surgical - 1st Half-year 2024-25: Consolidated Sales of €51.5m, +6.3% at Constant Exchange Rates
Amplitude Surgical (ISIN: FR0012789667, Mnemo: AMPLI, PEA-PME eligible), the French market leader in surgical technologies for lower limb orthopedics, announces its consolidated sales for the first ...
Amplitude Announces Fourth Quarter and Fiscal Year 2024 Financial Results
Recurring Revenue was $312 million, up 11% year-over-year Remaining performance obligations of $308.6 million, up 29% year-over-year Fourth quarter revenue of $78.1 million, up 9% year-over-year ...
Amplitude (AMPL) Receives a Hold from Scotiabank
Scotiabank analyst Nick Altmann maintained a Hold rating on Amplitude (AMPL – Research Report) today and set a price target of $12.00. The ...